Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco… - The Lancet Infectious …, 2012 - thelancet.com
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit… - The Lancet Infectious …, 2012 - Elsevier
BACKGROUND: The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit… - The Lancet Infectious …, 2012 - infona.pl
The extent of cross-protection is a key element in the choice of human papillomavirus (HPV)
vaccine to use in vaccination programmes. We compared the cross-protective efficacy of the …
vaccine to use in vaccination programmes. We compared the cross-protective efficacy of the …